DNA sequencing and genomic analysis instruments for research and clinical diagnostics
Illumina manufactures sequencing instruments and genomic analysis platforms at industrial scale—5,001–10,000 employees, global manufacturing footprint, and multi-year product roadmaps. The company is mid-transformation: adopting SAP S/4HANA and Databricks while replacing SAP ECC, signaling a shift toward real-time data pipelines and unified enterprise systems. Active hiring across sales (76 roles), engineering (74), and manufacturing (22) reflects simultaneous pressure to expand multiomics market reach and improve production cost and quality control.
Notable leadership hires: Director Real Estate, Procurement Lead, Head of Informatics Sales, AI Adoption Lead
Illumina designs and manufactures DNA and RNA sequencing instruments, array-based analysis systems, and associated software platforms used by research institutions, pharmaceutical companies, and clinical laboratories worldwide. The company generates revenue through instrument sales, consumables (reagents, sequencing kits), and software licensing. With 354 active open roles and hiring across 20+ countries, Illumina is scaling sales and engineering to support new product launches in multiomics and enter adjacent clinical diagnostic segments. Manufacturing and R&D remain core functions, reflecting the capital-intensive, regulated nature of the genomics hardware and assay business.
Illumina uses Workday (HR), SAP S/4HANA and ECC (ERP), Microsoft Office suite, Node.js, Angular, .NET/C# (backend), AWS/Azure (cloud), Docker/Kubernetes (containerization), Python/Apache Spark (data processing), Snowflake/dbt (analytics), and Power BI/Tableau (visualization).
Illumina posts roles in 20 countries: United States, United Kingdom, Canada, Germany, Sweden, Netherlands, France, Spain, Italy, Austria, China, Japan, South Korea, Taiwan, Singapore, Brazil, Colombia, Australia, South Africa, and Saudi Arabia.
Other companies in the same industry, closest in size